- call +1-201-465-4211
- email sales@mrinsights.biz
According to this study, over the next five years the Targeted RNA Sequencing market will register a 28.6% CAGR in terms of revenue, the global market size will reach $ 3018.8 million by 2025, from $ 1102.7 million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Targeted RNA Sequencing business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Targeted RNA Sequencing market by type, application, key manufacturers and key regions and countries.
This study considers the Targeted RNA Sequencing value and volume generated from the sales of the following segments:
Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
enrichment approaches
amplicon-based approaches
Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Research Institutes
Hospitals & Clinics
Biotechnology Company
Diagnostic Lab
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Thermo Fisher
Illumina
BGI
Eurofins
Roche Holdings
Macrogen
LabCorp
GENEWIZ
Berry Genomics
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Targeted RNA Sequencing consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Targeted RNA Sequencing market by identifying its various subsegments.
Focuses on the key global Targeted RNA Sequencing manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Targeted RNA Sequencing with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Targeted RNA Sequencing submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Targeted RNA Sequencing Consumption 2015-2025
2.1.2 Targeted RNA Sequencing Consumption CAGR by Region
2.2 Targeted RNA Sequencing Segment by Type
2.2.1 enrichment approaches
2.2.2 amplicon-based approaches
2.3 Targeted RNA Sequencing Consumption by Type
2.3.1 Global Targeted RNA Sequencing Consumption Market Share by Type (2015-2020)
2.3.2 Global Targeted RNA Sequencing Revenue and Market Share by Type (2015-2020)
2.3.3 Global Targeted RNA Sequencing Sale Price by Type (2015-2020)
2.4 Targeted RNA Sequencing Segment by Application
2.4.1 Research Institutes
2.4.2 Hospitals & Clinics
2.4.3 Biotechnology Company
2.4.4 Diagnostic Lab
2.5 Targeted RNA Sequencing Consumption by Application
2.5.1 Global Targeted RNA Sequencing Consumption Market Share by Type (2015-2020)
2.5.2 Global Targeted RNA Sequencing Value and Market Share by Type (2015-2020)
2.5.3 Global Targeted RNA Sequencing Sale Price by Type (2015-2020)
3 Global Targeted RNA Sequencing by Company
3.1 Global Targeted RNA Sequencing Sales Market Share by Company
3.1.1 Global Targeted RNA Sequencing Sales by Company (2018-2020)
3.1.2 Global Targeted RNA Sequencing Sales Market Share by Company (2018-2020)
3.2 Global Targeted RNA Sequencing Revenue Market Share by Company
3.2.1 Global Targeted RNA Sequencing Revenue by Company (2018-2020)
3.2.2 Global Targeted RNA Sequencing Revenue Market Share by Company (2018-2020)
3.3 Global Targeted RNA Sequencing Sale Price by Company
3.4 Global Targeted RNA Sequencing Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Targeted RNA Sequencing Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Targeted RNA Sequencing Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 Targeted RNA Sequencing by Regions
4.1 Targeted RNA Sequencing by Regions
4.2 Americas Targeted RNA Sequencing Consumption Growth
4.3 APAC Targeted RNA Sequencing Consumption Growth
4.4 Europe Targeted RNA Sequencing Consumption Growth
4.5 Middle East & Africa Targeted RNA Sequencing Consumption Growth
5 Americas
5.1 Americas Targeted RNA Sequencing Consumption by Countries
5.1.1 Americas Targeted RNA Sequencing Consumption by Countries (2015-2020)
5.1.2 Americas Targeted RNA Sequencing Value by Countries (2015-2020)
5.2 Americas Targeted RNA Sequencing Consumption by Type
5.3 Americas Targeted RNA Sequencing Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries
6 APAC
6.1 APAC Targeted RNA Sequencing Consumption by Regions
6.1.1 APAC Targeted RNA Sequencing Consumption by Regions (2015-2020)
6.1.2 APAC Targeted RNA Sequencing Value by Regions (2015-2020)
6.2 APAC Targeted RNA Sequencing Consumption by Type
6.3 APAC Targeted RNA Sequencing Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions
7 Europe
7.1 Europe Targeted RNA Sequencing by Countries
7.1.1 Europe Targeted RNA Sequencing Consumption by Countries (2015-2020)
7.1.2 Europe Targeted RNA Sequencing Value by Countries (2015-2020)
7.2 Europe Targeted RNA Sequencing Consumption by Type
7.3 Europe Targeted RNA Sequencing Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Spain
7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
8.1 Middle East & Africa Targeted RNA Sequencing by Countries
8.1.1 Middle East & Africa Targeted RNA Sequencing Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Targeted RNA Sequencing Value by Countries (2015-2020)
8.2 Middle East & Africa Targeted RNA Sequencing Consumption by Type
8.3 Middle East & Africa Targeted RNA Sequencing Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends
10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Targeted RNA Sequencing Distributors
10.3 Targeted RNA Sequencing Customer
11 Global Targeted RNA Sequencing Market Forecast
11.1 Global Targeted RNA Sequencing Consumption Forecast (2021-2025)
11.2 Global Targeted RNA Sequencing Forecast by Regions
11.2.1 Global Targeted RNA Sequencing Forecast by Regions (2021-2025)
11.2.2 Global Targeted RNA Sequencing Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.5.6 Spain Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Targeted RNA Sequencing Forecast by Type
11.8 Global Targeted RNA Sequencing Forecast by Application
12 Key Players Analysis
12.1 Thermo Fisher
12.1.1 Company Information
12.1.2 Targeted RNA Sequencing Product Offered
12.1.3 Thermo Fisher Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Thermo Fisher Latest Developments
12.2 Illumina
12.2.1 Company Information
12.2.2 Targeted RNA Sequencing Product Offered
12.2.3 Illumina Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Illumina Latest Developments
12.3 BGI
12.3.1 Company Information
12.3.2 Targeted RNA Sequencing Product Offered
12.3.3 BGI Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 BGI Latest Developments
12.4 Eurofins
12.4.1 Company Information
12.4.2 Targeted RNA Sequencing Product Offered
12.4.3 Eurofins Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Eurofins Latest Developments
12.5 Roche Holdings
12.5.1 Company Information
12.5.2 Targeted RNA Sequencing Product Offered
12.5.3 Roche Holdings Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Roche Holdings Latest Developments
12.6 Macrogen
12.6.1 Company Information
12.6.2 Targeted RNA Sequencing Product Offered
12.6.3 Macrogen Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 Macrogen Latest Developments
12.7 LabCorp
12.7.1 Company Information
12.7.2 Targeted RNA Sequencing Product Offered
12.7.3 LabCorp Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 LabCorp Latest Developments
12.8 GENEWIZ
12.8.1 Company Information
12.8.2 Targeted RNA Sequencing Product Offered
12.8.3 GENEWIZ Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 GENEWIZ Latest Developments
12.9 Berry Genomics
12.9.1 Company Information
12.9.2 Targeted RNA Sequencing Product Offered
12.9.3 Berry Genomics Targeted RNA Sequencing Sales, Revenue, Price and Gross Margin (2018-2020)
12.9.4 Main Business Overview
12.9.5 Berry Genomics Latest Developments
13 Research Findings and Conclusion
List of Tables
Table 1. Research Methodology
Table 2. Data Source
Table 3. Targeted RNA Sequencing Consumption CAGR by Region 2015-2025 ($ Millions)
Table 4. Major Player
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
